REGENXBIO Inc (NASDAQ: RGNX) stock closed at $7.80 on 3/18/25 after a major increase of 11.4%. Moreover, unusually high trading volume at 173% of normal accompanied the advance. The stock has risen 29.8% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
REGENXBIO has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. REGENXBIO has a neutral Appreciation Score of 40 but a poor Power Rating of 17, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment